Decreased processivity of A3G NPM was attributable to changes in sliding, but not jumping movements. by Anjuman Ara (540372)

Single mutations decrease drug susceptibility and increase fitness. by Linda L. Marcusson (261125)

Dynamin inhibitors decrease the viability of acute leukemia cells. by Christopher von Beek (11401835)

Decrease in equilibrium population size (<i>K</i>) for vole with repeated perturbations (mean ±1 SE). by Jacob Nabe-Nielsen (254477)

TMP decreased ROS generation in high glucose-treated endothelial cells. by Qiong Xu (204847)

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”

TMP decreased superoxide anions in high glucose-treated endothelial cells. by Qiong Xu (204847)

Vinpocetine inhibits carrageenan-induced decrease in antioxidant capacity. by Kenji W. Ruiz-Miyazawa (714809)

The ratios of SAP to DNA decrease in SLE murine model. by Weijuan Zhang (347468)

Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials. by Daria Van Tyne (168938)

“…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”

Inhibition of Rac1 decreases lamellipodia formation and increases endothelial permeability. by Jerome W. Breslin (548352)

Reduction of IL-8 is associated with a relevant decrease of GBA2 expression in CF bronchial cells. by Nicoletta Loberto (2224150)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…The corresponding cross section height measurements show a height decrease by slightly less than 100 nm (from ∼10 nm to −100 nm in the encircled area; lower panel); the arrow in the AFM images points to an intact intercellular connection before cutting (<b>E1</b>) and the disappearance thereof after cutting (<b>E2</b>). …”

Omeprazole (Ome) decreases IL-4-stimulated STAT6 binding to the endogenous eotaxin-3 promoter in (A) EoE1-T and (B) EoE2-T cells. by Xi Zhang (83736)

MPA decreases cell proliferation and PBMC response to activation. by Susan C. Irvin (708995)

Simvastatin decreases peroxynitrite, superoxide and iNOS production. by Mohammed Sabri (355717)

“…<b>D</b> and <b>E.</b> Western blot quantification of iNOS protein expression show that iNOS protein was significantly decreased by pre- (<b>D</b>, <i>P</i><0.01) but not post-SAH (<b>E</b>, <i>P></i>0.05) simvastatin treatment as compared to vehicle treated animals. …”

Disruption of Spatacsin decreases the regeneration of lysosomes in KO MEFs. by Rita-Eva Varga (784560)

“…<p><b>(A, G, K)</b> Autolysosomes defined as vesicles that stain for both Lamp1 and p62 are increased in KO compared to WT MEFs (Mean±SEM of n = 3 experiments; Student’s t-test: ** indicates p<0.01). …”

Omeprazole (Ome) decreases IL-4-stimulated RNA Pol II binding to the endogenous eotaxin-3 promoter in (A) EoE1-T and (B) EoE2-T cells. by Xi Zhang (83736)

VPA treatment and senescence induction is associated with decreased neurogenesis. by Muriel Rhinn (406515)

Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)